Security key
471871103
- Security type / class
- Equity / COM
- Total 13F shares
- 93,692,255
- Total 13F value
- $168,805,066
- Share change
- +79,073,323
- Put/Call ratio
- 50%
- SEC-reported price per share
- $1.81
- Number of holders
- 45
- Value change
- +$142,866,970
- Number of buys
- 41
- Number of sells
- 6
Open additional details 1 more signal available
Report period
Q1 2023
Institutions
45
Top holders
10
JSPR full security history
Ownership snapshot
Full 13F holder table
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of JSPR - JASPER THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Qiming U.S. Healthcare Fu...
Disclosed value leader
Qiming U.S. Healthcare Fu...
Comparable rows
0/15
Latest evidence
27 Jan 2023
3/4/5
13F
Highest disclosed value: $5,525,844
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Qiming U.S. Healthcare Fund II, L.P. has the largest disclosed position value at $5.53M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Qiming U.S. Healthcare Fund II, L.P.'s linked filing trail.
Disclosed position value
Top 5
Qiming U.S. Healthcare Fund II, L.P.
$5.53M
ROCHE HOLDING LTD
$2.95M
Abingworth LLP
$2.72M
Amplitude Healthcare Holdings LLC
$1.49M
Qiming U.S. Ventures Management, LLC
$2.83M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund II, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$5,525,844
8,519,648 shares
|
— | 27 Jan 2023 |
| ROCHE HOLDING LTD |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$2,950,874
4,549,606 shares
|
— | 25 Jan 2023 |
| Abingworth LLP |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$2,718,594
5,628,558 shares
|
— | 31 Dec 2022 |
| Amplitude Healthcare Holdings LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,491,780
2,300,000 shares
|
— | 24 Sep 2021 |
| Qiming U.S. Ventures Management, LLC |
13F
Company
|
—
denominator unverified
|
$2,826,405
5,852,982 shares
|
— | 31 Dec 2022 |
| Balaji Venkataraman |
3/4/5
FORMER DIRECTOR AND OFFICER
|
—
denominator unverified
|
$1,491,780
2,300,000 shares
|
— | 24 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
93,692,255
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
45
Q1 2023 holders
45
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|